Cyberonics announces FDA approval of The AspireSR(R) generator for VNS Therapy(R)
Cyberonics announced FDA approval of the AspireSR® generator for the VNS Therapy® System - the first and only VNS Therapy System that provides responsive stimulation to heart-rate increases that are often associated with seizures in people with epilepsy. June 02, 2015